Unleashing AI in Drug Discovery: Prospects and Challenges
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Pathologic Stage IV Cutaneous Melanoma AJCC v8
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB14913
5-methyl-2'-fluoroarauracil F-18
0
Active Not Recruiting
1
DB00112
Bevacizumab
1
Recruiting
1
DB01373
Calcium
1
Active Not Recruiting
1
DB04690
Camptothecin
1
Active Not Recruiting
1
DB01101
Capecitabine
1
Active Not Recruiting
1
DB12218
Capivasertib
1
Recruiting
1
DB00958
Carboplatin
1
Active Not Recruiting
1
DB11059
Carboxymethylcellulose
1
Recruiting
1
DB14681
Cortisone
1
Active Not Recruiting
1
DB00531
Cyclophosphamide
1
Active Not Recruiting
1
DB00531
Cyclophosphamide
1
Recruiting
1
DB00694
Daunorubicin
1
Active Not Recruiting
1
DB00997
Doxorubicin
1
Active Not Recruiting
1
DB08871
Eribulin
1
Active Not Recruiting
1
DB01175
Escitalopram
1
Active Not Recruiting
1
DB00544
Fluorouracil
1
Active Not Recruiting
1
DB17293
Hiltonol
1
Recruiting
1
DB14999
Human interferon beta
1
Active Not Recruiting
1
DB00619
Imatinib
1
Completed
1
DB06186
Ipilimumab
1
Active Not Recruiting
2
DB06186
Ipilimumab
1
Completed
1
DB06186
Ipilimumab
1
Recruiting
1
DB00762
Irinotecan
1
Active Not Recruiting
1
DB00650
Leucovorin
1
Active Not Recruiting
1
DB11596
Levoleucovorin
1
Active Not Recruiting
1
DB00123
Lysine
1
Recruiting
1
DB00959
Methylprednisolone
1
Active Not Recruiting
1
DB09035
Nivolumab
1
Active Not Recruiting
2
DB09035
Nivolumab
1
Recruiting
2
DB09074
Olaparib
1
Active Not Recruiting
1
DB00526
Oxaliplatin
1
Active Not Recruiting
1
DB01229
Paclitaxel
1
Active Not Recruiting
1
DB01229
Paclitaxel
1
Recruiting
1
DB09037
Pembrolizumab
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Recruiting
2
DB00642
Pemetrexed
1
Active Not Recruiting
1
DB00635
Prednisone
1
Active Not Recruiting
1
DB00020
Sargramostim
1
Recruiting
1
DB11942
Selinexor
1
Active Not Recruiting
1
DB00864
Tacrolimus
1
Active Not Recruiting
1
DB01030
Topotecan
1
Active Not Recruiting
1
DB16626
Tyrosinase
1
Active Not Recruiting
1
DB11595
Atezolizumab
1 / 2
Recruiting
1
DB11945
Avelumab
1 / 2
Recruiting
1
DB15387
Bintrafusp alfa
1 / 2
Completed
1
DB14681
Cortisone
1 / 2
Recruiting
1
DB00531
Cyclophosphamide
1 / 2
Active Not Recruiting
1
DB01262
Decitabine
1 / 2
Active Not Recruiting
1
DB11714
Durvalumab
1 / 2
Recruiting
1
DB00065
Infliximab
1 / 2
Recruiting
1
DB17107
Lifileucel
1 / 2
Active Not Recruiting
1
DB00959
Methylprednisolone
1 / 2
Recruiting
1
DB15721
Natural Killer Cell
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Recruiting
1
DB09037
Pembrolizumab
1 / 2
Recruiting
1
DB14904
Pimasertib
1 / 2
Completed
1
DB05992
Plinabulin
1 / 2
Recruiting
1
DB00635
Prednisone
1 / 2
Recruiting
1
DB00853
Temozolomide
1 / 2
Recruiting
1
DB09033
Vedolizumab
1 / 2
Recruiting
1
DB11595
Atezolizumab
2
Active Not Recruiting
1
DB00112
Bevacizumab
2
Active Not Recruiting
1
DB11967
Binimetinib
2
Recruiting
3
DB05239
Cobimetinib
2
Active Not Recruiting
1
DB08912
Dabrafenib
2
Active Not Recruiting
1
DB11718
Encorafenib
2
Recruiting
2
DB01611
Hydroxychloroquine
2
Active Not Recruiting
1
DB06186
Ipilimumab
2
Active Not Recruiting
2
DB06186
Ipilimumab
2
Recruiting
2
DB15994
Methane
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB09035
Nivolumab
2
Recruiting
3
DB09037
Pembrolizumab
2
Active Not Recruiting
1
DB09037
Pembrolizumab
2
Recruiting
1
DB06273
Tocilizumab
2
Active Not Recruiting
1
DB08911
Trametinib
2
Active Not Recruiting
1